Down Syndrome (DS) Completed Phase 1 Trials for Insulin glulisine (DB01309)
Also known as: Downs Syndrome / Down's Syndrome / Trisomy 21 / Down Syndrome / Trisomy 21 (morphologic abnormality) / Trisomy 21 NOS / (Down's syndrome - trisomy 21) or (mongolism) or (trisomy 21) or (trisomy 22) / Syndrome Down's / Mongolism / Down's syndrome NOS (disorder) / Down's syndrome NOS / Complete trisomy 21 syndrome (disorder)
Indication | Status | Phase |
---|---|---|
DBCOND0061020 (Down Syndrome (DS)) | Completed | 1 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02432716 | Investigation of the Safety of Intranasal Glulisine in Down Syndrome | Treatment |